Literature DB >> 16034185

Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Jerilynn C Prior1.   

Abstract

The purpose of this review is to put into a useful clinical context the changing over time of basic ovarian-pituitary-hypothalamic relationships during perimenopause. "Perimenopause" means changes in ovarian hormones, feedback relationships, and clinical experiences beginning in women ages 35-50 with regular flow and ending 1 yr after the final menstrual flow. A key observation must be explained--estradiol levels are increased in perimenopause. Inhibin B levels are lower and activin may be higher in midlife, menstruating women. These changes probably cause higher follicular phase FSH levels--"endogenous ovarian hyperstimulation" results. The positive estradiol feedback on LH is also disturbed--midcycle LH peaks and mid-luteal slow-frequency, high-amplitude LH pulses are less frequent. In addition to higher levels, estradiol receptors may increase in tissues of symptomatic women. Despite hyperstimulation of follicles, progesterone levels and luteal phase lengths are paradoxically decreased--reasons probably include LH peak disruptions and estrogen-stimulated greater corticotrophin-mediated reproductive suppression. In summary, disturbed feedback relationships causing higher and unpredictable estrogen and lower progesterone levels occur throughout perimenopause, especially during regular cycles. Prospective, population-based research is needed to systematically relate these feedback hormonal changes to clinical characteristics and to allow a diagnosis of perimenopause in regularly cycling midlife women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034185     DOI: 10.1385/ENDO:26:3:297

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  49 in total

1.  Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychosocial stress in healthy young men.

Authors:  C Kirschbaum; N Schommer; I Federenko; J Gaab; O Neumann; M Oellers; N Rohleder; A Untiedt; J Hanker; K M Pirke; D H Hellhammer
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

2.  Female reproductive aging is marked by decreased secretion of dimeric inhibin.

Authors:  C K Welt; D J McNicholl; A E Taylor; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

3.  Progesterone-induced changes in sleep in male subjects.

Authors:  E Friess; H Tagaya; L Trachsel; F Holsboer; R Rupprecht
Journal:  Am J Physiol       Date:  1997-05

4.  Staging the menopausal transition: data from the TREMIN Research Program on Women's Health.

Authors:  Phyllis Kernoff Mansfield; Molly Carey; Amy Anderson; Susannah Heyer Barsom; Patricia Bartholow Koch
Journal:  Womens Health Issues       Date:  2004 Nov-Dec

Review 5.  Role of inhibin-related peptides as intragonadal regulators.

Authors:  J K Findlay; X Sai; L Shukovski
Journal:  Reprod Fertil Dev       Date:  1990       Impact factor: 2.311

6.  Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay.

Authors:  N P Groome; P J Illingworth; M O'Brien; I Cooke; T S Ganesan; D T Baird; A S McNeilly
Journal:  Clin Endocrinol (Oxf)       Date:  1994-06       Impact factor: 3.478

7.  Short communication: seasonal onset of menopause?

Authors:  János Garai; Szabolcs Világi; István Répásy; Miklós Koppán; József Bódis
Journal:  Hum Reprod       Date:  2004-06-09       Impact factor: 6.918

8.  Sociodemographic characteristics, biological factors, and symptom reporting in midlife women.

Authors:  J Wilbur; A M Miller; A Montgomery; P Chandler
Journal:  Menopause       Date:  1998       Impact factor: 2.953

9.  Menometrorrhagia in the perimenopause is associated with increased serum estradiol.

Authors:  M H Moen; H Kahn; K S Bjerve; T B Halvorsen
Journal:  Maturitas       Date:  2004-02-20       Impact factor: 4.342

10.  Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve.

Authors:  D B Seifer; A C Gardiner; G Lambert-Messerlian; A L Schneyer
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

View more
  23 in total

Review 1.  Gonadal hormones and cognitive aging: a midlife perspective.

Authors:  Victor W Henderson
Journal:  Womens Health (Lond)       Date:  2011-01

2.  Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation.

Authors:  Cheryl S Watson; Yow-Jiun Jeng; Mikhail Y Kochukov
Journal:  FASEB J       Date:  2008-06-09       Impact factor: 5.191

3.  Site-specific variance in radius and tibia bone strength as determined by muscle size and body mass.

Authors:  Andrew William Frank; Megan Crystal Labas; James Duncan Johnston; Saija Annukka Kontulainen
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

4.  Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A.

Authors:  A L Lukefahr; J B Frye; L E Wright; S L Marion; P B Hoyer; J L Funk
Journal:  Calcif Tissue Int       Date:  2012-01-17       Impact factor: 4.333

5.  Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma.

Authors:  Koji Matsuo; Todd B Sheridan; Seiji Mabuchi; Kiyoshi Yoshino; Kosei Hasegawa; Kimberley D Studeman; Dwight D Im; Neil B Rosenshein; Lynda D Roman; Anil K Sood
Journal:  Gynecol Oncol       Date:  2014-03-25       Impact factor: 5.482

6.  Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer.

Authors:  Jinlong Jian; Qing Yang; Jisen Dai; Jonathan Eckard; Deborah Axelrod; Debrah Axelrod; Julia Smith; Xi Huang
Journal:  Free Radic Biol Med       Date:  2010-12-28       Impact factor: 7.376

Review 7.  The menopause and aging, a comparative perspective.

Authors:  Caleb E Finch
Journal:  J Steroid Biochem Mol Biol       Date:  2013-04-10       Impact factor: 4.292

Review 8.  Does iron have a role in breast cancer?

Authors:  Xi Huang
Journal:  Lancet Oncol       Date:  2008-08       Impact factor: 41.316

9.  Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2010-05       Impact factor: 5.682

Review 10.  Hormone response in ovarian cancer: time to reconsider as a clinical target?

Authors:  Francesmary Modugno; Robin Laskey; Ashlee L Smith; Courtney L Andersen; Paul Haluska; Steffi Oesterreich
Journal:  Endocr Relat Cancer       Date:  2012-11-09       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.